Thorne Healthtech

Thorne Healthtech FCF Conversion

Delisted

The FCF Conversion Rate (FCF/EBITDA) of Thorne Healthtech (THRN) as of Oct 12, 2026 is -80.64 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 38.28 % — a change of -310.67% (lower).

FCF Conversion

-80.64 %

YoY

-310.67%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Thorne Healthtech is 2022 -80.64 % . FCF Conversion Rate (FCF/EBITDA) of Thorne Healthtech was 2021 38.28 % . It decreases by -310.67% lower compared to the previous year.

The Thorne Healthtech FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2019
63.44 USD
Jan 1, 2020
-604.92 USD
Jan 1, 2021
38.28 USD
Jan 1, 2022
-80.64 USD
The Thorne Healthtech FCF Conversion history
YEARFCF ConversionYoY
-80.64 %-310.67%
38.28 %-106.33%
-604.92 %-1,053.59%
63.44 %—
Access this data via the Eulerpool API

Thorne Healthtech Stock analysis

What does Thorne Healthtech do? Thorne Healthtech Inc is a leading company in the health and wellness industry based in the USA. Founded in 1984 by Al Czap, a former Olympic champion and naturopath, Thorne Healthtech Inc has focused on producing high-quality dietary supplements. The history of Thorne Healthtech Inc began with the goal of improving people's health and well-being. The founder, Czap, believed that it was necessary to strengthen the body from the inside out to achieve long-term health. He started integrating naturopathic principles into his work and developing natural-based dietary supplements. Thorne Healthtech Inc's business model is based on the development and production of high-quality dietary supplements tailored to the needs of customers. The company has a strong research and development department that constantly develops new innovative products and improves existing ones. Thorne Healthtech Inc adheres to strict quality standards in manufacturing, and the products are produced under the supervision of experts. The company has divided itself into different divisions to offer customers a wide range of health products. One of the divisions is Performance Products, specifically tailored to athletes. This can include dietary supplements for post-workout recovery, collagen for joint health support, or supplements to enhance endurance and strength. Another division is Immune System Products. Here, Thorne Healthtech Inc offers a variety of dietary supplements designed to strengthen the immune system and protect the body against diseases and infections. This includes vitamins, herbs, minerals, and probiotic supplements. Another important area is Nutrient Supplements. Thorne Healthtech Inc produces a wide range of dietary supplements that can help provide the body with the necessary amount of nutrients. These include folic acid, magnesium, vitamin B12, and vitamin C. A particularly important area for the health industry is the Laboratory Tests sector. Thorne Healthtech Inc offers various tests for interested customers to better understand their health condition. These include tests for vitamins, minerals, probiotics, allergies, and more. In conclusion, Thorne Healthtech Inc is a company specialized in improving the physical and mental health of people through the production of high-quality dietary supplements. The company has a long history and extensive experience in naturopathy, and follows strict quality standards in product manufacturing. With a wide range of health and wellness products and excellent customer service, Thorne Healthtech Inc aims to support its customers in leading healthier lives. Thorne Healthtech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Thorne Healthtech stock

FCF Conversion Rate (FCF/EBITDA) of Thorne Healthtech is -80.64 % in 2022.

FCF Conversion Rate (FCF/EBITDA) of Thorne Healthtech changed from 38.28 % to -80.64 %, representing a -310.67% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Thorne Healthtech since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Thorne Healthtech with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

Cash Flow — Thorne Healthtech

All Key Metrics — Thorne Healthtech